FDA Investigator Lawton W Lum

Lawton W Lum has conducted inspections on 52 sites in 5 countries as of 09 Dec 2002. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
52
Last Inspection Date:
09 Dec 2002
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Denmark, Germany, Ireland, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Lawton W Lum:
Adam S Freeman, Alice A Blair, Alla Dubrovsky, Althea A Williams, Amogh Pathi, Andrea P Scott, Angel K Sandhu, Ashleigh P Wodushek, Beverly A Gallauresi, Carl Lee, Carla J Lundi, Catherine J Laufmann, Cathryn M Groehnert, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, Charles R Sawyer, Christine M Parmentier, Christopher W Buser, Cindy W Lewis, Courtney R Bolton, Cynthia L Ford, Daniel C Geffin, Daniel J Roberts, Darlene B Almogela, David A Lum, Debra D Devlieger, Dolores Harper, Dorothy W Lee, Douglas A Campbell, Elizabeth A Dakan, Ellen J Tave, Elodie X Tong Lin, Eric J Heinze, Eric W Anderson, Felix J Marrero, Gamal A Norton, Gary L Zaharek, Geoffrey M Leist, Gerald N Mcgirl, DDS, Greg K Keshishyan, Ismael Garibay, James A Lane, Jamie P Webb, Janice Wai, Jazmine M Welcher, Jeffrey M Watson, Jeffrey S Buckser, Jeffrey W Shrifter, DPM, Jolene S Hedgecock, Joseph A Seitz, III, Juan A Morales, Jude C Dikes, Kacie M Crowther, Kenya Destin, Keren Arkin, Kevin P Foley, Kimberly L Anderson, Kin T Moy, Kinh Q Mac, Kristin M Abaonza, L Gnnmassimia Massimilla, PharmD, Lance A Finnical, Lance Mde Souza, MBA, Linda Linh N Adams, Lisa H Nakagawa, Lorraine N Dixon, Lorraine N Williams, LT Mark A Chen, MPH, Lydia S Chan, Maida Henesian (NMI), Marie K Kinkade, Mark E Chan, Mark I Nakano, Mary C Acton, Mary R Hole, Matthew A Walburger, Matthew D Schnittker, Matthew M Vernon, Mcgrewp, Melvin Dorin, Monique C Lo, Nicolas C Tolosa, III, Patrick B Cummings, Paul L Jones, Paul M Kawamoto, Perry H Gambrell, Phillip M Pontikos, Phung, Quynh H Strandberg, Ramon E Martinez, Randall P Zielinski, Rashonda N Rucker, Raymond T Oji, Roberta K Smith, Ronald P Boyce, Sabino S Camacho, Sandra S Saniga, Seema S Singh, Sergio Chavez (NMI), Seyyida Saterfield, Shelley H Beausoleil, Sheri S Oliver, Stephanie T Durso, Stephen D Eich, Steve P Yost, Steven B Chiu, Susan M Jackson, Terrence Gee, Thanh M Andrews, Thomas E Friel, Timothy C Grome, Travelle D Mason, Victoria L Morgan, Wen Jun Peng, Wendy S Shenk, William J Weis, Xiaojun Yan, Yehualashet A Gessesse

Lawton W Lum's Documents

Publish Date Document Type Title
November, 2000 EIR Hospira Inc - EIR, 2000-11-02
August, 2000 EIR Novo Nordisk A/S - Hiller?d - EIR, 2000-08-17
December, 2001 FDA 483 Genetix Corp. - Form 483, 2001-12-10
September, 2001 FDA 483 Philips Medical Systems - Form 483, 2001-09-25
June, 2000 EIR Hospira Inc - EIR, 2000-06-21
December, 2001 FDA 483 Response Genetix Corp. - Form 483R, 2001-12-28
February, 2000 EIR Abbott Vascular, Inc. - EIR, 2000-02-09
February, 2002 FDA 483 ABB Concise Optical Group LLC - Form 483, 2002-02-11
March, 2000 FDA 483 Intuitive Surgical, Inc. - Form 483, 2000-03-15
December, 2001 EIR Genetix Corp. - EIR, 2001-12-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more